News

Novotech announced that it has signed a Memorandum of Understanding (MOU) with South Korean medical institution, The Asan Medical Center.

Cliantha Research is proud to announce the acquisition of Inflamax Research. Inflamax has locations in Toronto, ON; Neptune, NJ and Newark, NJ. Cliantha Research will have the capabilities to perform Phase I, II, III and IV clinical research in North America. Inflamax’s world renowned expertise in inflammatory disease research and patented natural allergen Environmental Exposure Chambers (EEC) shall allow Cliantha to conduct Asthma, Allergy, Ophthalmology, Tobacco research plus specialized pulmonary/respiratory therapeutic studies.

Initial findings from a DIA study of patient-centric initiatives in drug development reveal pharma’s desire to move toward true patient-centricity, but approaches to implementation are varied.

Certara announced the launch of a new solution for preparing, analyzing and submitting pharmacokinectic data in Clinical Data Exchange Standards Consortium (CDISC) format.Read the full release here

A certified CDISC provider and leader in pharmacometrics, Certara has developed a new solution which will enable sponsors to achieve new compliance requirements effortlessly

ePatientFinder and Rep Network have announced a partnership that aims to provide clinical trial access to patients nationally.

BioPlan has released its updated textbook, A Quick Guide to Clinical Trials, 2nd Edition.

Updated employee announcements, business news, awards and recognition in the industry today.

Medidata announces the acquisition of eClinical technology company, Mytrus Inc. Medidata will add Mytrus’ eConsent solution, Enroll, into the Medidata Clinical Cloud.

Why taking a right-sized approach to real-world studies will help keep sites and patients around for the duration.

Examining early learnings from approaches used to comply with EMA’s requirement to publish anonymized versions of clinical study reports and other submission documents, including how privacy protection was balanced against data utility.

In today’s value-driven healthcare system, real-world studies are increasingly becoming mandated by regulators as a condition of approval for new medicines.

In continuing our series on patient centricity, we are adding the digital perspective from inside of a biopharmaceutical enterprise. In this interview with Jeremy Sohn, VP, Global Head of Digital Business Development & Licensing at Novartis, we will delve into how biopharmaceutical enterprises are incorporating digital strategy into patient centric study execution, and elaborate on some of the cultural challenges of adopting novel study methods.

YPrime has announced the release of its of its data-driven electronic clinical outcome assessment (eCOA) technology platform.

An international panel of industry experts has concluded that randomized, controlled clinical trials provide the fastest and most reliable way to identify the risks and benefits of treatment candidates for infectious disease outbreaks.

MedNet Solutions announced that its eClinical solution, iMedNet, now leverages Amazon Web Services, as well as ClearDATA's security and infrastructure services.

Jeremy Sohn, VP, Global Head of Digital Business Development & Licensing at Novartis, delves into how biopharma is incorporating digital strategy into the execution of patient centric studies.

Accenture has announced a collaboration with BioCelerate, a subsidiary of TransCelerate, to develop a platform.

TrialScope, a company focused on clinical study transparency, has launched ATLAS Global Compliance.

PMG Research and Devana Solutions, LLC have announced a long-term subscription agreement.